Response to Dual Crizotinib and Osimertinib Treatment in a...

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Deng, Lei, Kiedrowski, Lesli A., Ravera, Elizabeth, Cheng, Haiying, Halmos, Balazs
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.04.007
Date:
September, 2018
File:
PDF, 638 KB
english, 2018
Conversion to is in progress
Conversion to is failed